Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect ...

The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Evercore ISI Group on January 5, 2026. The analyst firm set a price target for $105.00 expecting EXAS to rise to within 12 ...

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called ...

As the US one-cent coin disappears from circulation, stores are putting up signs asking for exact change or advising customers that their change will be rounded. Retailers from AutoZone to Whole Foods ...

Julie Young is an experienced financial writer and editor. She specializes in financial analysis in capital planning and investment management. Gordon Scott has been an active investor and technical ...